606 related articles for article (PubMed ID: 28978530)
41. A pathogenetic role for endothelin-1 in peritoneal dialysis-associated fibrosis.
Busnadiego O; Loureiro-Álvarez J; Sandoval P; Lagares D; Dotor J; Pérez-Lozano ML; López-Armada MJ; Lamas S; López-Cabrera M; Rodríguez-Pascual F
J Am Soc Nephrol; 2015 Jan; 26(1):173-82. PubMed ID: 25012164
[TBL] [Abstract][Full Text] [Related]
42. miR-15a-5p suppresses peritoneal fibrosis induced by peritoneal dialysis via targeting VEGF in rats.
He Q; Wen L; Wang L; Zhang Y; Yu W; Zhang F; Zhang W; Xiao J; Wen X; Zhao Z
Ren Fail; 2020 Nov; 42(1):932-943. PubMed ID: 32909490
[TBL] [Abstract][Full Text] [Related]
43. Vascular endothelial growth factor-mediated peritoneal neoangiogenesis in peritoneal dialysis.
Shi Y; Hu Y; Cui B; Zhuang S; Liu N
Perit Dial Int; 2022 Jan; 42(1):25-38. PubMed ID: 33823711
[TBL] [Abstract][Full Text] [Related]
44. Tanshinone IIA attenuates peritoneal fibrosis through inhibition of fibrogenic growth factors expression in peritoneum in a peritoneal dialysis rat model.
Chunming J; Miao Z; Cheng S; Nana T; Wei Z; Dongwei C; Yuan F
Ren Fail; 2011; 33(3):355-62. PubMed ID: 21401363
[TBL] [Abstract][Full Text] [Related]
45. Caffeic acid phenethyl ester restores mitochondrial homeostasis against peritoneal fibrosis induced by peritoneal dialysis through the AMPK/SIRT1 pathway.
Lu Y; Gao L; Zhang W; Zeng Y; Hu J; Song K
Ren Fail; 2024 Dec; 46(1):2350235. PubMed ID: 38721924
[TBL] [Abstract][Full Text] [Related]
46. The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats.
Hur E; Bozkurt D; Timur O; Bicak S; Sarsik B; Akcicek F; Duman S
Clin Nephrol; 2012 Jan; 77(1):1-7. PubMed ID: 22185962
[TBL] [Abstract][Full Text] [Related]
47. Parthenolide, an NF-κB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-β/Smad pathway.
Zhang Y; Huang Q; Chen Y; Peng X; Wang Y; Li S; Wu J; Luo C; Gong W; Yin B; Xiao J; Zhou W; Peng F; Long H
Int Immunopharmacol; 2020 Jan; 78():106064. PubMed ID: 31838448
[TBL] [Abstract][Full Text] [Related]
48. Nitro-oleic acid inhibits the high glucose-induced epithelial-mesenchymal transition in peritoneal mesothelial cells and attenuates peritoneal fibrosis.
Su W; Wang H; Feng Z; Sun J
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F457-F467. PubMed ID: 31760768
[TBL] [Abstract][Full Text] [Related]
49. Morphologic changes of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models.
Io H; Hamada C; Ro Y; Ito Y; Hirahara I; Tomino Y
Kidney Int; 2004 May; 65(5):1927-36. PubMed ID: 15086936
[TBL] [Abstract][Full Text] [Related]
50. Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells.
Lho Y; Do JY; Heo JY; Kim AY; Kim SW; Kang SH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33947038
[TBL] [Abstract][Full Text] [Related]
51. Oral supplementation with sulodexide inhibits neo-angiogenesis in a rat model of peritoneal perfusion.
Pletinck A; Van Landschoot M; Steppan S; Laukens D; Passlick-Deetjen J; Vanholder R; Van Biesen W
Nephrol Dial Transplant; 2012 Feb; 27(2):548-56. PubMed ID: 21750165
[TBL] [Abstract][Full Text] [Related]
52. Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of vascular endothelial growth factor and connective tissue growth factor in cultured human peritoneal mesothelial cells.
Liu FY; Xiao L; Peng YM; Duan SB; Liu H; Liu YH; Ling GH; Yuan F; Chen JX; Fu X; Zhu JL
Chin Med J (Engl); 2007 Feb; 120(3):231-6. PubMed ID: 17355828
[TBL] [Abstract][Full Text] [Related]
53. Suramin inhibits the development and progression of peritoneal fibrosis.
Xiong C; Liu N; Fang L; Zhuang S; Yan H
J Pharmacol Exp Ther; 2014 Nov; 351(2):373-82. PubMed ID: 25168661
[TBL] [Abstract][Full Text] [Related]
54. Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2.
Yuan J; Fang W; Ni Z; Dai H; Lin A; Cao L; Qian J
Pediatr Nephrol; 2009 Jan; 24(1):163-70. PubMed ID: 18751736
[TBL] [Abstract][Full Text] [Related]
55. [Effect of shenshuning recipe on the extracellular matrix accumulation of the peritoneal fibrosis rats].
Yang HT; Shang YC; Cao SL; Dou YT; Huang Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1683-9. PubMed ID: 24517070
[TBL] [Abstract][Full Text] [Related]
56. Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.
Padwal M; Siddique I; Wu L; Tang K; Boivin F; Liu L; Robertson J; Bridgewater D; West-Mays J; Gangji A; Brimble KS; Margetts PJ
Nephrol Dial Transplant; 2017 Jan; 32(1):50-61. PubMed ID: 27190383
[TBL] [Abstract][Full Text] [Related]
57. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.
Yoshio Y; Miyazaki M; Abe K; Nishino T; Furusu A; Mizuta Y; Harada T; Ozono Y; Koji T; Kohno S
Kidney Int; 2004 Oct; 66(4):1677-85. PubMed ID: 15458466
[TBL] [Abstract][Full Text] [Related]
58. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells.
Xiao L; Sun L; Liu FY; Peng YM; Duan SB
Ther Apher Dial; 2010 Feb; 14(1):27-34. PubMed ID: 20438517
[TBL] [Abstract][Full Text] [Related]
59. Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
Costalonga EC; de Freitas LJ; Aragone DDSP; Silva FMO; Noronha IL
PLoS One; 2017; 12(9):e0184302. PubMed ID: 28873458
[TBL] [Abstract][Full Text] [Related]
60. Role of tyrosine kinase inhibition with imatinib in an encapsulating peritoneal sclerosis rat model.
Velioglu A; Tugtepe H; Asicioglu E; Yilmaz N; Filinte D; Arikan H; Koc M; Tuglular S; Kaya H; Ozener C
Ren Fail; 2013; 35(4):531-7. PubMed ID: 23473055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
